BBC.comWegovy wins 25,000 new sign-ups a week in US15 days agoNatalie ShermanBy Natalie Shermanmore_vert
Financial TimesNovo Nordisk cuts price of weight loss drug Wegovy as competition heats up15 days agomore_vert
ReutersNovo Nordisk trims price for blockbuster obesity drug as competition heats up15 days agoMaggie Fick & Stine Buch JacobsenBy Maggie Fick & Stine Buch Jacobsenmore_vert
매일경제Model and entrepreneur Kim Kardashian and Tesla CEO Elon Musk are known to have been effective, so t.. - MK14 days agomore_vert
Zacks Investment ResearchNovo Nordisk (NVO) Q1 Earnings Beat, GLP-1 Drugs Boost Sales15 days agomore_vert
Barron'sMarijuana Reclassification Reports Lift Tilray Stock, Other Marijuana SharesApr 30Angela PalumboBy Angela Palumbomore_vert
MM+M OnlineBig Pharma Q1 earnings roundup: Novo, Moderna and Regeneron report15 days agoJack O'BrienBy Jack O'Brienmore_vert
Sky NewsIan King Business Podcast: Goldman Sachs removes bonus cap, demand for gold and Novo Nordisk forecasts15 days agomore_vert
NTB KommunikasjonNovo Nordisk's sales increased by 22% in Danish kroner and by 24% at constant exchange rates to DKK 65.3 billion in ...15 days agomore_vert
CNBCNovo Nordisk falls after strong Q1 results, Mizuho's Jared Holz talks what's next for the company15 days agomore_vert
BloombergNovo Trades at Hefty Discount to Lilly Even After 350% Rally15 days agoKit Rees & Thyagaraju AdinarayanBy Kit Rees & Thyagaraju Adinarayanmore_vert
Pharmaceutical TechnologyNovo Nordisk aims for market domination, boasts $1.5bn obesity sales in Q115 days agoPhalguni DeswalBy Phalguni Deswalmore_vert
Yahoo FinanceNovo Nordisk A/S (NYSE:NVO) Q1 2024 Earnings Call Transcript14 days agoInsider MonkeyBy Insider Monkeymore_vert
ReutersNovo Nordisk: Wegovy, Ozempic prices in US fell in Q115 days agoJosephine Mason, Maggie Fick & Jason NeelyBy Josephine Mason, Maggie Fick & Jason Neelymore_vert
BioSpaceNovo Nordisk’s Wegovy Pricing Drops as Competition Heats Up with Eli Lilly14 days agoGreg SlabodkinBy Greg Slabodkinmore_vert
MarketWatchNovo Nordisk Raises FY Sales and Op Profit Guidance15 days agoDominic ChoppingBy Dominic Choppingmore_vert
MorningstarNovo Nordisk says starter doses of weight-loss drug surge as company hikes financial outlook15 days agoSteve GoldsteinBy Steve Goldsteinmore_vert
Seeking AlphaNovo Nordisk GAAP EPADR of DKK 5.68, revenue of DKK 65.35B; updates FY24 outlook15 days agoMeghavi SinghBy Meghavi Singhmore_vert
Detroit NewsNovo boosts Wegovy shipments as Lilly rivalry pressures prices15 days agoNaomi KresgeBy Naomi Kresgemore_vert
The Wall Street JournalNovo Nordisk Stock Falls After Pricing Pressure Mounts for Wegovy15 days agoPeter LoftusBy Peter Loftusmore_vert
QuartzWeight loss drug sales surge, COVID vax sales sink, 'junk' patents14 days agoBruce GilBy Bruce Gilmore_vert
Simply Wall StResults: Novo Nordisk A/S Beat Earnings Expectations And Analysts Now Have New Forecasts13 days agomore_vert
ForbesOzempic Maker Novo Nordisk Beats Profit Forecasts Amid Weight Loss Drug Frenzy15 days agoRobert HartBy Robert Hartmore_vert
FuturismNovo Nordisk To Slash Prices On Buzzy Drugs Ozempic and Wegovy14 days agoNoor Al-SibaiBy Noor Al-Sibaimore_vert
Proactive Investors UKNovo Nordisk continues to impress, says buyer Citi14 days agoPhilip Whiterow & William FarringtonBy Philip Whiterow & William Farringtonmore_vert
Peeblesshire NewsGrowing demand for weight loss treatments drives sales at drugmaker Novo Nordisk15 days agomore_vert
geneonlineNovo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion14 days agomore_vert
MedrivaPrice of Wegovy, Mounjaro Dump in the US and the UK15 days agoMason WalkerBy Mason Walkermore_vert
FinimizeNovo Nordisk increased its profit projections15 days agoRussell BurnsBy Russell Burnsmore_vert
Investing.comNovo Nordisk trims price for blockbuster obesity drug as competition heats up15 days agoMaggie Fick & Stine Buch JacobsenBy Maggie Fick & Stine Buch Jacobsenmore_vert
Proactive Investors AustraliaNovo Nordisk ups guidance buts cuts Wegovy price15 days agoOliver Haill & Philip WhiterowBy Oliver Haill & Philip Whiterowmore_vert
Healthnews.comDespite Shortages, 25,000 People Start This Weight Loss Drug Weekly15 days agoMira MillerBy Mira Millermore_vert
TradingViewEarnings report: Novo Nordisk cashes in on weight loss drug fever with better-than-expected results15 days agomore_vert
Business Insider IndiaBlockbuster weight-loss drug Wegovy's sales just doubled — and could heat up even more with a price cut14 days agoShubhangi GoelBy Shubhangi Goelmore_vert
Daily SabahNovo Nordisk lifts 2024 outlook on weight-loss drug demand | Daily Sabah15 days agomore_vert
Fox Business25K Americans starting Wegovy weekly as supply increases and prices drop, drugmaker says14 days agoDaniella Alessandra GenoveseBy Daniella Alessandra Genovesemore_vert
Investor's Business DailyNovo Nordisk Dips As Wegovy Sales Double, But Miss Forecasts15 days agoAllison GatlinBy Allison Gatlinmore_vert
BenzingaDemand Soars For Novo Nordisk's Weight-Loss Drug Wegovy Despite Supply Constraints And Eli Lilly Competit15 days agomore_vert
WXOW.comAt least 25000 people in the US are starting weight-loss drug Wegovy each week, drugmaker says15 days agoMeg TirrellBy Meg Tirrellmore_vert
AxiosOzempic, Wegovy shortages weigh on Novo Nordisk outlook15 days agoNathan BomeyBy Nathan Bomeymore_vert
InvestopediaNovo Nordisk's Earnings Beat Estimates on Surging Demand for Its Weight-Loss Drugs15 days agoAaron McDadeBy Aaron McDademore_vert
Fast CompanyNovo Nordisk stock price sinks today despite Wegovy sales boom15 days agoEllie StevensBy Ellie Stevensmore_vert
The GuardianDanish firm behind weight-loss drug Wegovy raises profit forecast to £15.3bn15 days agoJulia KolleweBy Julia Kollewemore_vert
KAKEAt least 25000 people in the US are starting weight-loss drug Wegovy each week, drugmaker says15 days agomore_vert
Business InsiderNovo Nordisk plans to cut US price for blockbuster obesity drug Wegovy15 days agoShubhangi GoelBy Shubhangi Goelmore_vert